Adherence to Antipsychotics in Schizophrenia (Record no. 93783)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 04398nam a22005415i 4500 |
| 001 - CONTROL NUMBER | |
| control field | 978-88-470-2679-7 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | DE-He213 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20140220082526.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 131127s2014 it | s |||| 0|eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9788847026797 |
| -- | 978-88-470-2679-7 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1007/978-88-470-2679-7 |
| Source of number or code | doi |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RC434.2-574 |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MMH |
| Source | bicssc |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED105000 |
| Source | bisacsh |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 616.89 |
| Edition number | 23 |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Sacchetti, Emilio. |
| Relator term | author. |
| 245 10 - TITLE STATEMENT | |
| Title | Adherence to Antipsychotics in Schizophrenia |
| Medium | [electronic resource] / |
| Statement of responsibility, etc | by Emilio Sacchetti, Antonio Vita, Alberto Siracusano, Wolfgang Fleischhacker. |
| 264 #1 - | |
| -- | Milano : |
| -- | Springer Milan : |
| -- | Imprint: Springer, |
| -- | 2014. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | XII, 159 p. 10 illus., 1 illus. in color. |
| Other physical details | online resource. |
| 336 ## - | |
| -- | text |
| -- | txt |
| -- | rdacontent |
| 337 ## - | |
| -- | computer |
| -- | c |
| -- | rdamedia |
| 338 ## - | |
| -- | online resource |
| -- | cr |
| -- | rdacarrier |
| 347 ## - | |
| -- | text file |
| -- | |
| -- | rda |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 1 Poor adherence to antipsychotic medication in people with schizophrenia: diffusion, consequences, and contributing factors -- Premise -- Role of antipsychotics in the treatment of schizophrenia -- Compliance versus adherence -- Assessment of medication adherence -- Frequency of poor adherence to antipsychotics -- Consequences of poor adherence to antipsychotics -- Determinants and moderators of adherence to antipsychotics -- Present and medium-term perspectives -- Closing Remarks -- 2 Pharmacological strategies to enhance adherence in schizophrenia -- Introduction -- Pharmacological factors contributing to non-adherence: efficacy, side effects, regimen, co-therapies -- First vs Second generation antipsychotics: efficacy, tolerability and the adherence issue -- Long-acting injectable antipsychotics -- Conclusion. 3 Non-pharmacological strategies to enhance adherence and continuity of care in schizophrenia -- Introduction -- Factors Influencing (non-)adherence in Schizophrenia -- Interventions to Enhance Adherence. Research and Clinical Evidence -- Comprehensive Review of Psychosocial and Programmatic Interventions to Enhance Adherence to Antipsychotic Medication in Schizophrenia -- Summary of Main Results and Evidences -- Conclusions and Future Directions -- 4 Psychological issues in improving adherence and alliance -- The patient-doctor relationship as a determinant of adherence to treatment -- Alliance and psychodynamic issues -- Towards the concept of concordance of the therapeutic project. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc | Poor adherence to therapy is one of the main obstacles to treatment effectiveness in schizophrenia. It is the main determinant of relapse, hospitalization, symptom persistence, and poor psychosocial functioning and outcome. Adherence to treatment is affected by various factors related to the disease characteristics, to the patient him- or herself, to the treatment, and to the therapeutic relationship. Some of these factors are modifiable, and both pharmacological and non-pharmacological strategies have been developed for this purpose. This book addresses the different aspects of adherence to treatment in schizophrenia and related disorders in a systematic but easy-to-use manual format. Chapters focus on a full range of issues, including pharmacological and non-pharmacological strategies to enhance adherence and continuity of care, relevant psychological factors, the importance of the patient-doctor relationship, and the need for an alliance with other care-givers. Adherence to Antipsychotics in Schizophrenia will be an invaluable asset for all who are involved in the care of patients with schizophrenia. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Medicine. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Neurosciences. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Toxicology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Psychiatry. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Psychopharmacology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Psychotherapy. |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Medicine & Public Health. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Psychiatry. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Psychopharmacology. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Psychotherapy. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Neurosciences. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Pharmacology/Toxicology. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Vita, Antonio. |
| Relator term | author. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Siracusano, Alberto. |
| Relator term | author. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Fleischhacker, Wolfgang. |
| Relator term | author. |
| 710 2# - ADDED ENTRY--CORPORATE NAME | |
| Corporate name or jurisdiction name as entry element | SpringerLink (Online service) |
| 773 0# - HOST ITEM ENTRY | |
| Title | Springer eBooks |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Display text | Printed edition: |
| International Standard Book Number | 9788847026780 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | http://dx.doi.org/10.1007/978-88-470-2679-7 |
| 912 ## - | |
| -- | ZDB-2-SME |
No items available.